Related Experiment Videos
Clinicopathologic study of lupus nephritis
S Chakrabarti1, A K Ghosh, J Bose
1Centre for Transfusion Medicine and Clinical Research, Calcutta.
Journal of the Indian Medical Association
|March 4, 1999
Summary
Systemic lupus erythematosus (SLE) patients with lupus nephritis showed Class IV lesions most frequently, correlating with poorer prognosis and fewer remissions despite immunosuppressive therapy. Class II lupus nephritis offered the best prognosis.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organs, including the kidneys, leading to lupus nephritis.
- Accurate classification of lupus nephritis is crucial for predicting patient outcomes and guiding treatment strategies.
Purpose of the Study:
- To classify lupus nephritis based on WHO criteria.
- To correlate histological findings with clinical presentation, autoantibody profiles, treatment response, and prognosis.
Main Methods:
- 35 SLE patients with renal lesions underwent kidney needle biopsies.
- Clinical data, laboratory tests (hematology, biochemistry, urinalysis), and autoantibody levels (ANA, anti-dsDNA, LE cells, RF) were analyzed.
- WHO classification was used to categorize lupus nephritis histology.
Main Results:
- Class IV lupus nephritis was most common (42.8%), associated with active lesions and limited complete remission (4/15 cases) with immunosuppressive therapy.
- Class II (14.3%) and Class III (22.8%) nephritis showed better remission rates (4/5 and 6/8 cases, respectively).
- Rheumatoid factor (RF)-positive cases exhibited milder renal lesions.
Conclusions:
- Histological classification of lupus nephritis is vital for prognosis.
- Class IV lupus nephritis presents a significant challenge, requiring further therapeutic advancements.
- Early identification and classification of lupus nephritis can optimize patient management and outcomes.